[VRDN] YoY Quarter Result on 30-Jun-2022 [#Q2]

Stock
[VRDN] Viridian Therapeutics, Inc.
Announcement Date
15-Aug-2022
Financial Year
2022
Quarter
30-Jun-2022 [#Q2]
Profit Trend
QoQ- -15.66%
YoY- -64.17%
Quarter Report
VRDN's Result
VRDN's Financial Summary
View:
Show?
Quarter Result
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Revenue 72 72 256 1,090 168 2,514 2,182 -43.33%
PBT -64,993 -55,063 -29,491 -17,964 -6,435 -8,896 -8,714 39.73%
Tax 0 4,378 227 9 33 204 361 -
NP -64,993 -55,063 -29,491 -17,964 -6,435 -8,896 -8,714 39.73%
Tax Rate - - - - - - - -
Total Cost 65,065 55,135 29,747 19,054 6,603 11,410 10,896 34.65%
Ratio Analysis
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
NP Margin -90,268.05 -76,476.39 -11,519.92 -1,648.07 -3,830.36 -353.86 -399.36 146.60%
Per Share
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
EPS -1.02 -1.27 -1.06 -2.22 -1.82 -4.31 -4.31 -21.33%
EPS Diluted -1.02 -1.27 -1.06 -2.22 -1.82 -4.31 -4.31 -21.33%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.